β受体阻滞剂可预防心肌梗死后的心源性死亡：那么为什么如此多的心肌梗死幸存者出院时未服用β受体阻滞剂呢？
Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers?
作者信息
Viskin S, Barron H V
出版信息
Am J Cardiol. 1996 Oct 1;78(7):821-2. doi: 10.1016/s0002-9149(96)00428-6.
PMID:8857489
Abstract
Too often, infarct survivors are discharged from physician's care and/or hospital stay without beta-blocker therapy. This reflects concerns by physicians regarding precipitation of adverse effects. Ironically, many of the infarct survivors not receiving beta blockers could actually derive the greatest benefits from this treatment.
摘要
梗死幸存者常常在未接受β受体阻滞剂治疗的情况下就从医生的护理中出院和/或结束住院治疗。这反映了医生对不良反应发生的担忧。具有讽刺意味的是，许多未接受β受体阻滞剂治疗的梗死幸存者实际上可能从这种治疗中获益最大。
Zotero 插件